TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
287,675
|
275,812
|
253,159 |
Financial expenses |
9,466
|
7,322
|
183,893 |
Earnings before taxes |
-6,008
|
31,995
|
-124,271 |
Total assets |
407,214
|
333,146
|
321,915 |
Current assets |
159,182
|
137,831
|
141,526 |
Current liabilities |
117,795
|
41,035
|
32,204 |
Equity capital |
273,263
|
275,768
|
272,405 |
- share capital |
44,345
![]() |
44,345
![]() |
44,345 |
Employees (average) |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
67.1%
|
82.8%
|
84.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
Current ratio |
135.1%
|
335.9%
|
439.5% |
Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
Change turnover |
11,863
|
22,653
|
25,030 |
Change turnover % |
4%
|
9%
|
11% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.